EditorialEditorial
Quantitative Clinical Rheumatology: Why Is a Test for Anti-CCP Antibodies Included in Most Routine Care for Rheumatoid Arthritis While a HAQ/MDHAQ Remains Largely a Research Tool?
THEODORE PINCUS, YUSUF YAZICI and MARTIN J. BERGMAN
The Journal of Rheumatology August 2009, 36 (8) 1563-1564; DOI: https://doi.org/10.3899/jrheum.080563
THEODORE PINCUS
YUSUF YAZICI
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- Pincus T,
- Sokka T,
- Kautiainen H
- 5.↵
- 6.↵
- Pincus T,
- Bergman MJ,
- Yazici Y,
- Hines P,
- Raghupathi K,
- Maclean R
- 7.↵
- Pincus T,
- Swearingen CJ,
- Bergman M,
- Yazici Y
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- Engel GL
- 15.↵
- 16.↵
- Pincus T,
- Huizinga TWJ,
- Yazici Y
- 17.↵
- Yazici Y,
- Sokka T,
- Kautiainen H,
- Swearingen C,
- Kulman I,
- Pincus T
In this issue
The Journal of Rheumatology
Vol. 36, Issue 8
1 Aug 2009
Quantitative Clinical Rheumatology: Why Is a Test for Anti-CCP Antibodies Included in Most Routine Care for Rheumatoid Arthritis While a HAQ/MDHAQ Remains Largely a Research Tool?
THEODORE PINCUS, YUSUF YAZICI, MARTIN J. BERGMAN
The Journal of Rheumatology Aug 2009, 36 (8) 1563-1564; DOI: 10.3899/jrheum.080563
Quantitative Clinical Rheumatology: Why Is a Test for Anti-CCP Antibodies Included in Most Routine Care for Rheumatoid Arthritis While a HAQ/MDHAQ Remains Largely a Research Tool?
THEODORE PINCUS, YUSUF YAZICI, MARTIN J. BERGMAN
The Journal of Rheumatology Aug 2009, 36 (8) 1563-1564; DOI: 10.3899/jrheum.080563